Andere Suchmöglichkeiten:
functional inhibition » functional integration, fractional inhibitory
fusion inhibition » site inhibition
inhibition system » inhibitor systeme
inhibition after » institution after, inhibition assay
pain institution » _ institution
pump inhibition » pump inhibitor, pump inhibitors
pain inhibition » kanal inhibition
institution ehe » institution en, institution _, institution 145
point infection » joint infection, joint infections, upon infection
hpaiv infection » hcv infection, hpv infektion
infektion after » infektion anti, dissection after
pre infection » oral infection, site infection, upon infection
hiv infektion » _ infektion
functional inhibition » functional integration, fractional inhibitory
fusion inhibition » site inhibition
inhibition system » inhibitor systeme
inhibition after » institution after, inhibition assay
pain institution » _ institution
pump inhibition » pump inhibitor, pump inhibitors
pain inhibition » kanal inhibition
institution ehe » institution en, institution _, institution 145
point infection » joint infection, joint infections, upon infection
hpaiv infection » hcv infection, hpv infektion
infektion after » infektion anti, dissection after
pre infection » oral infection, site infection, upon infection
hiv infektion » _ infektion
1
2
Möllers, Mareike, von Wahlde, Marie-Kristin, Schuler, Franziska, Mellmann, Alexander, Böing, Christian Wilhelm, Schwierzeck, Vera, Schneider, Julia Sophie, Kampmeier, Stefanie
2022
Schlagwörter:
“...MRSA surgical site infection COVID-19 infection control outbreak management contact precautions...”2022
3
4
5
6
7
Leyh-Bannurah, Sami-Ramzi, Prugger, Christof, Koning, Maurits NC de, Goette, Hartmut, Lellé, Ralph J.
2014
Schlagwörter:
“...Papillomavirus infections Cervix uteri Ethiopia DNA probes HPV Epidemiology Risk factors Sub-Sahara...”2014
8
9
10
11
monozentrische retrospektive Querschnittsstudie des Krankenhauspersonals
Inhaltsverzeichnis:
“....2.3 Risikofaktoren für einen schweren Verlauf der SARS-CoV-2-Infektion ..... 17 -- 1.2.4 Risikogruppen ..... 17 -- 1...”
12
13
14